Higher body mass index (BMI) after diagnosis is linked to better survival outcomes in patients with localized renal cell ...
In a retrospective analysis, patients with colon cancer taking GLP-1 agonists had a 62% lower risk of 5-year mortality ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback